PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Prviate Bank.  In an article published in September 2020, our unique technology platforms were highlighted, following our discovery of 68 genes that could be responsible for some of the more severe symptoms experienced by some people infected by the SARS-CoV-2 virus.

To read the article in full, visit https://privatebank.barclays.com/news-and-insights/2020/september/pandemic-precision-medicine/?cid=mm03soc_sc01ca07cr17co121te01ts18&linkId=100000016578707#